Claire McKenna

Summary

Affiliation: University of York
Country: UK

Publications

  1. doi request reprint Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments Required
    Claire McKenna
    Centre for Health Economics, University of York, York, North Yorkshire, UK Electronic address
    Value Health 18:865-75. 2015
  2. doi request reprint Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injury
    Claire McKenna
    Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO10 5DD, UK Electronic address
    J Clin Epidemiol 70:183-90. 2016
  3. doi request reprint Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York, UK
    Med Decis Making 31:853-65. 2011
  4. doi request reprint Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure
    Claire McKenna
    Centre for Health Economics, University of York, York, UK
    Value Health 15:420-8. 2012
  5. doi request reprint Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal
    Claire McKenna
    Centre for Health Economics, University of York, York, UK
    Pharmacoeconomics 30:35-46. 2012
  6. doi request reprint The EOS 2D/3D X-ray imaging system: a cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure
    Rita Faria
    Centre for Health Economics, University of York, York, UK
    Eur J Radiol 82:e342-9. 2013
  7. doi request reprint Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal
    Jane Burch
    Centre for Reviews and Dissemination CRD, University of York, York, UK
    Pharmacoeconomics 30:991-1004. 2012
  8. doi request reprint Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York, United Kingdom
    Int J Technol Assess Health Care 26:175-82. 2010
  9. doi request reprint Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York YO10 5DD, United Kingdom
    J Health Econ 29:170-81. 2010
  10. doi request reprint Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis
    Rita Faria
    Centre for Health Economics, University of York, York, UK Electronic address
    Value Health 17:772-82. 2014

Detail Information

Publications14

  1. doi request reprint Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments Required
    Claire McKenna
    Centre for Health Economics, University of York, York, North Yorkshire, UK Electronic address
    Value Health 18:865-75. 2015
    ....
  2. doi request reprint Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injury
    Claire McKenna
    Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO10 5DD, UK Electronic address
    J Clin Epidemiol 70:183-90. 2016
    ....
  3. doi request reprint Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York, UK
    Med Decis Making 31:853-65. 2011
    ..In doing so, the authors are able to account for the range of opportunity cost associated with research and evaluate a number of..
  4. doi request reprint Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure
    Claire McKenna
    Centre for Health Economics, University of York, York, UK
    Value Health 15:420-8. 2012
    ....
  5. doi request reprint Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal
    Claire McKenna
    Centre for Health Economics, University of York, York, UK
    Pharmacoeconomics 30:35-46. 2012
    ..However, following the response from a large number of consultees and commentators, NICE revised its preliminary guidance to allow the use of the drug in a specific subgroup of AF patients with additional cardiovascular risk factors...
  6. doi request reprint The EOS 2D/3D X-ray imaging system: a cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure
    Rita Faria
    Centre for Health Economics, University of York, York, UK
    Eur J Radiol 82:e342-9. 2013
    ..To evaluate the cost-effectiveness of the EOS(®) 2D/3D X-ray imaging system compared with standard X-ray for the diagnosis and monitoring of orthopaedic conditions...
  7. doi request reprint Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal
    Jane Burch
    Centre for Reviews and Dissemination CRD, University of York, York, UK
    Pharmacoeconomics 30:991-1004. 2012
    ..The Appraisal Committee recommended that omalizumab should not be routinely provided for the treatment of severe persistent allergic asthma in children aged 6-11 years...
  8. doi request reprint Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York, United Kingdom
    Int J Technol Assess Health Care 26:175-82. 2010
    ....
  9. doi request reprint Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions
    Claire McKenna
    Centre for Health Economics, University of York, Heslington, York YO10 5DD, United Kingdom
    J Health Econ 29:170-81. 2010
    ....
  10. doi request reprint Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis
    Rita Faria
    Centre for Health Economics, University of York, York, UK Electronic address
    Value Health 17:772-82. 2014
    ..There has been some controversy on whether the costs of omalizumab outweigh its benefits for severe persistent allergic asthma...
  11. doi request reprint Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study
    Simon Walker
    Centre for Health Economics, University of York, Alcuin A Block, Heslington, York YO10 5DD, UK
    Heart 99:873-81. 2013
    ..To evaluate the cost-effectiveness of diagnostic strategies for coronary heart disease (CHD) derived from the CE-MARC study...
  12. doi request reprint Ipilimumab for Previously Untreated Unresectable Malignant Melanoma: A Critique of the Evidence
    Christina Giannopoulou
    Centre for Health Economics, Alcuin A Block, University of York, Heslington, York, YO10 5DD, UK
    Pharmacoeconomics 33:1269-79. 2015
    ..Following consideration of the additional evidence and the responses from a large number of consultees and commentators, the committee recommended ipilimumab as an option for adults with previously untreated advanced melanoma. ..
  13. doi request reprint Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis
    Claire McKenna
    Centre for Health Economics, University of York, York, UK
    Rheumatology (Oxford) 48:558-63. 2009
    ..To assess the cost-effectiveness of providing practical training to general practitioners (GPs) in shoulder problems, and administering a local anaesthetic (lignocaine) vs steroidal (cortisone) injection...
  14. pmc A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system
    Ros Wade
    Centre for Reviews and Dissemination, University of York, York YO10 5DD, UK
    Eur Spine J 22:296-304. 2013
    ..To evaluate the available evidence for the clinical effectiveness of the EOS(®) 2D/3D X-ray imaging system for the evaluation and monitoring of scoliosis and other relevant orthopaedic conditions...